| Drug Name |
Naratriptan |
| Drug ID |
BADD_D01535 |
| Description |
Naratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches. |
| Indications and Usage |
For the acute treatment of migraine attacks with or without aura in adults. |
| Marketing Status |
approved; investigational |
| ATC Code |
N02CC02 |
| DrugBank ID |
DB00952
|
| KEGG ID |
D08255
|
| MeSH ID |
C106783
|
| PubChem ID |
4440
|
| TTD Drug ID |
D0T3KI
|
| NDC Product Code |
69452-340; 69452-341; 23155-054; 42043-130; 42043-131; 23155-055; 50090-6162; 0054-0278; 0054-0279 |
| UNII |
QX3KXL1ZA2
|
| Synonyms |
naratriptan | N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide | GR 85548A | naratriptan hydrochloride | N-methyl-3-(1-methyl-4-piperidyl)indole-5-ethanesulfonamide monohydrochloride | 1H-indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride | Naramig | Amerge | Colatan |
